J. Goldman & Co LP Invests $567,000 in Celcuity Inc. (NASDAQ:CELC)

J. Goldman & Co LP purchased a new position in Celcuity Inc. (NASDAQ:CELC - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 43,345 shares of the company's stock, valued at approximately $567,000. J. Goldman & Co LP owned 0.12% of Celcuity as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds also recently modified their holdings of the company. Summit Investment Advisors Inc. increased its position in shares of Celcuity by 49.5% in the fourth quarter. Summit Investment Advisors Inc. now owns 3,421 shares of the company's stock worth $45,000 after purchasing an additional 1,132 shares during the period. Aquatic Capital Management LLC bought a new position in shares of Celcuity in the fourth quarter worth $50,000. The Manufacturers Life Insurance Company bought a new position in shares of Celcuity in the fourth quarter worth $142,000. Bleakley Financial Group LLC bought a new position in shares of Celcuity in the fourth quarter worth $146,000. Finally, Trexquant Investment LP bought a new position in shares of Celcuity in the fourth quarter worth $152,000. Institutional investors own 63.33% of the company's stock.

Wall Street Analyst Weigh In

A number of research analysts recently commented on the company. HC Wainwright restated a "buy" rating and issued a $27.00 price target on shares of Celcuity in a research report on Tuesday, April 1st. Needham & Company LLC reiterated a "buy" rating and issued a $29.00 target price on shares of Celcuity in a research report on Thursday. Five research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat, the company currently has an average rating of "Buy" and a consensus target price of $30.80.

Celcuity Price Performance

Celcuity stock traded up $0.09 during midday trading on Friday, reaching $10.61. The company's stock had a trading volume of 136,962 shares, compared to its average volume of 299,331. Celcuity Inc. has a 52 week low of $7.58 and a 52 week high of $19.77. The company has a current ratio of 10.35, a quick ratio of 10.36 and a debt-to-equity ratio of 0.65. The business has a 50-day moving average price of $10.15 and a 200-day moving average price of $11.67. The stock has a market cap of $401.47 million, a PE ratio of -4.07 and a beta of 0.56.

Celcuity (NASDAQ:CELC - Get Free Report) last released its earnings results on Wednesday, May 14th. The company reported ($0.86) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.95) by $0.09. On average, sell-side analysts predict that Celcuity Inc. will post -2.62 EPS for the current year.

Celcuity Company Profile

Celcuity Inc, a clinical stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for the treatment.